Neuropeptide Y (NPY) and agouti-related peptide (AGRP) can produce hyperphagia, reduce energy expenditure, and promote triglyceride deposition in adipose depots. As these two neuropeptides are coexpressed within the hypothalamic arcuate nucleus and mediate a major portion of the obesity caused by leptin signaling deficiency, we sought to determine whether the two neuropeptides mediated identical or complementary actions. Because of separate neuropeptide receptors and signal transduction mechanisms, there is a possibility of distinct encoding systems for the feeding and energy expenditure aspects of leptin-regulated metabolism. We have genetically added NPY deficiency and/or AGRP deficiency to LEPR deficiency isolated to AGRP cells. Our results indicate that the obesity of LEPR deficiency in AGRP/NPY neurons can produce obesity with either AGRP or NPY alone with AGRP producing hyperphagia while NPY promotes reduced energy expenditure. The absence of both NPY and AGRP prevents the development of obesity attributable to isolated LEPR deficiency in AGRP/NPY neurons. Operant behavioral testing indicated that there were no alterations in the reward for a food pellet from the AGRP-specific LEPR deficiency. (Endocrinology 152: 883-889, 2011) T wo orexigenic neuropeptides, neuropeptide Y (NPY) and agouti-related peptide (AGRP) are released by the same set of neurons within the arcuate nucleus of the hypothalamus (1). The expression of both neuropeptide genes are increased in negative caloric balance and loss of leptin signaling (2-4). Both NPY and AGRP are considered to be important in producing hyperphagia, obesity, and infertility in cases of absent or diminished leptin signaling, such as complete leptin deficiency (5), lipodystrophy (6), and diet-induced obesity (7), although their relative contributions have not been directly compared.
that NPY and AGRP play in mediating leptin's actions on feeding and energy balance. We have previously shown that loss of Lepr expression in AGRP/NPY neurons caused an obesity phenotype attributable to transient hyperphagia and reduced energy expenditure in young male mice (8) . In this report, we have further ablated expression of Agrp and/or Npy from AGRP/NPY neurons of female mice, using the appropriate knockout alleles for the neuropeptide genes to assess the remaining phenotypes (5, 17) . Our results suggest that, in this case of ablated leptin signaling in hypothalamic AGRP/NPY neurons, AGRP is the primary driver for hyperphagia, whereas NPY is the mediator for reducing on energy expenditure. Both AGRP and NPY are necessary to manifest the full phenotypes of hyperphagia and reduced energy expenditure attributable to loss of leptin signaling in AGRP/NPY neurons. Finally, we report on operant behavioral testing as a means of assessing the strength of a food reward in these genetically altered mice.
Materials and Methods

Animals
The Agrp-CRE Lepr-flox/flox, N6 equivalent on the FVB strain, have been previously described, and a genotyping protocol of peripheral tissues was used to eliminate mice with ectopic expression of the Agrp-CRE transgene (8) . The Agrp KO (17) and the Npy KO alleles (5), maintained on a mixed C57BL/6 ϫ 129 background, were bred into the Agrp-CRE Lepr-flox/flox stock. All mice were maintained on this mixed background of FVB ϫ C57BL/6 ϫ 129. Mice were fed PicoLab Mouse Diet 20 5058 (an irradiated mouse breeder chow with 20% protein and minimal 9% fat; LabDiet; PMI Nutrition International, Brentwood, MO) and water ad libitum unless stated. Genotyping was done by PCR-based assays on DNA obtained from ear clips. All procedures were reviewed and approved by the institution's animal care committee, conforming to accepted standards of humane animal care.
Energy balance studies: meal patterns, calorimetry, and locomotion
Mice were individually housed in metabolic chambers maintained at 20 -22 C on a 12-h light, 12-h dark cycle with lights on at 0800 h. Mice maintained in the standard vivarium were maintained on a 14-h light, 10-h dark cycle with lights on at 0600 h. Metabolic measurements (oxygen consumption, food intake, locomotor activity) were obtained continuously using a CLAMS (Columbus Instruments, Columbus, OH) open circuit indirect calorimetry system. Mice were acclimated for 5-7 d within the chambers before collection of calorimetry data. Calorimetry data are normalized to individual lean body mass as determined by magnetic resonance spectroscopy, as suggested by Butler and Kozak (18) . Gas fractions were measured for 1 min at 8-min intervals. Data were analyzed in hourly time bins as well as daily time bins over a 5-d measurement period. Mice were provided with PicoLab Mouse Diet 20 5058 powdered diet (LabDiet; PMI Nutrition International, Brentwood, MO) and tap water ad libitum. Presented results contain data collected over 5-7 d after at least 2-4 d of adaptation to the metabolic cages.
Body mass and body composition determinations
Body mass was measured to the nearest 0.01 g. Body composition was determined by magnetic resonance spectroscopy using an ECHO magnetic resonance spectroscopy instrument (Echo Medical Systems, Houston, TX).
Operant behavior test
A standard operant chamber (Med Associates, Inc, St. Albans, VT) for mice was used. One wall of the chamber had a hole equipped with a dim light and a photo beam. Poking the hole interrupted the beam and resulted in the delivery of a 20-mg food pellet into the hole. We used Dustless Precison Pellets 20 mg, Fat Calories (35%) Rodent Purified Diet (Bio-Serv, Frenchtown, NJ). Twelve identical chambers were used in sound-attenuating boxes. The experiment was controlled by the MED-PC system using in-house software.
The mice were fasted from 0800 h to 1500 h and given 1-h session of nose-poke (FR1, FR2, PR1, or PR2) from 1500 h to 1600 h, and from 1600 h to 0800 h mice were fed with PicoLab Mouse Diet 20 5058 ad libitum.
At week 1 and week 2, the mice were trained for the foodreinforced response. Initially, the response was reinforced under a fixed ratio schedule (FR1), in which each nose poke was followed by the delivery of food pellet. The training continued until the animal got at least 10 reinforcements in a session (the response criterion) for three consecutive sessions. When the criterion was met, the ratio was set to two (FR2), in which every two nose pokes were followed by the delivery of food pellet. At the end of week 2, the mice failed to obtain 10 reinforcements under the FR2 schedule were not included in the further analysis.
Afterwards, the nose-poke session was set to a progressive ratio schedule (PR1 for week 3 and PR2 for week 4) , in which the number of responses required to obtain food was gradually increased. Initially, the number was set to 1. Every time the animal got the food within 300s, the ratio was increased to 2, 3, 4, 5, 6, 7 . . . (PR1) or 3, 5, 7, 9, 11, 13 . . . (PR2). If the animal failed to get food within the limited time, the test was terminated and the ratio immediately before termination was defined as the breaking point (19) .
Data and statistical analysis
Data are expressed as means with SD or SE. Comparisons between groups were performed using the unpaired one-tailed Student's t test.
Results
The loss of NPY does not reduce adiposity in AGRP:Lepr ؊/؊ mice
We initially set up a cross to examine the impact of ablating Npy expression in mice without Lepr expression in AGRP/NPY neurons. These mice were similar to our previously reported line with the addition of the Npy knockout allele, using Agrp-CRE Lepr-flox/flox Npy We did this to generate the four genotypes simultaneously and to be able to compare the genotype groups from the same parents. Body weights and body compositions (Table 1) ), the presence or loss of NPY did not affect body weight, fat mass, and body fat fraction, although both groups were significantly heavier and had more fat than the Lepr-intact mice. Interestingly, we noted that the fat-free mass of NPY-null AGRP:Lepr Ϫ/Ϫ male mice was not significantly higher than the two non-CRE cohorts, in contradistinction from the Npy ϩ/Ϫ AGRP:Lepr Ϫ/Ϫ male mice which had increased fat-free mass (about 4 g or greater than 10% of body mass) compared with the three other genotypes, including the NPY-null AGRP:Lepr Ϫ/Ϫ male mice.
These observations on body composition and body mass extended, in general, to the females, with both of the AGRP-CRE Lepr-flox/flox female cohorts having more body mass and fat mass than the non-CRE cohorts (Tables  1 and 2 ). The cohorts in Tables 1 and 2 are distinct as the mice listed in Table 1 were produced as described above, whereas the mice listed in Table 2 were generated by a breeding scheme described in the next section using males that were Agrp Ϫ/Ϫ Npy-/-AGRP:Lepr Ϫ/Ϫ and females that were Npy Ϫ/Ϫ Lepr-flox/flox. We noted that the effect of Npy genotype on fat-free mass was much less pronounced in females than in the males. Female NPY-null AGRP:Lepr Ϫ/Ϫ mice had a similar fat-free mass compared with the Npy-intact females, although Npy-intact LEPRnull females had slightly higher fat-free masses (Table 1) , ϳ1.5 g more than Npy-intact females (ϳ6.7% of body mass). Thus, we decided to focus on females as the smaller magnitude of differences in fat-free masses would simplify interpretations of indirect calorimetry data, as evidenced by ongoing discussion in the literature (18, 20) . We should note that the NPY-null females had more body mass and more fat mass than NPY-intact females although the NPYnull AGRP:Lepr Ϫ/Ϫ female mice had increased body mass and fat mass, as well as increased body fat percentage, even when compared with the NPY-null females. ) to generate the experimental groups in all subsequent studies.
Increased numbers of meals account for the hyperphagia of NPY-null AGRP:Lepr
Daily food intakes were higher for the NPY-null AGRP: Lepr Ϫ/Ϫ female mice, compared with NPY-null female mice while oxygen consumption and physical activity measures were not different between the two groups (Table 2). Meal pattern analyses indicated that the hyperphagia was attributable to an increase in meal frequency (Table 1) rather than increases in meal size. As AGRP is still expressed in the NPY-null AGRP:Lepr Ϫ/Ϫ mice, it is likely that AGRP is responsible for the hyperphagia and consequent increased fat mass. (Table 3) . Indirect calorimetry (Table 3 , Fig. 1 ) indicated lower oxygen consumption rates for the AGRP-null AGRP: Lepr Ϫ/Ϫ mice along with lowered carbon dioxide production, compared with the AGRP-null mice. The differences were small but significant when 24-h expenditure was calculated. Over the 24-h recording period, the AGRP-null AGRP:Lepr Ϫ/Ϫ mice showed a decrease in VO 2 and VCO 2 near the end of the light phase (between 1400 h and 1800 h). This decrease in energy expenditure was not associated with any increases in physical activity during that time interval (Table 3) . As NPY is still expressed in these mice, it is reasonable to assume that NPY may be mediating these effects on energy expenditure. (Table 4) . Furthermore, we did not observe any differences in feeding pattern (data not shown). The decreased energy expenditure that was observed in AGRP-null AGRP:Lepr Ϫ/Ϫ mice was not observed in the AGRP-null NPY-null AGRP: Lepr Ϫ/Ϫ females, suggesting that the absence of NPY was responsible for eliminating the enhanced energy expenditure during the end of the light phase.
Ablation of Agrp and Npy normalizes body composition of AGRP:Lepr
Ablation of Lepr signaling in AGRP/NPY neurons does not affect operant behavior for a food reward
We trained mice of all six genotypes to perform nosepokes for a 35% fat (by weight) pellet under a progressive ratio schedule. All of the mice were able to learn the task after several training sessions. We observed no difference in the break points between any of the groups with either a PR1 or a PR2 schedule (Tables 2-4) , suggesting that the reward for the 35% fat pellet was not altered due to any of the genetic manipulations. This was a surprising result as we had observed hyperphagia and increased meal frequencies in the NPY-null AGRP:Lepr Ϫ/Ϫ mice. Moreover, AGRP infusions have been shown to increase operant behavior for high fat diets (21). The data are presented as means and standard error for each genotype group. Female mice (n ϭ 4 -8) were 3-4 months of age. An asterisk denotes a significant difference (P Ͻ 0.05, one-tailed t test).
Discussion
Two neuropeptides released by the AGRP/NPY neuron mediate different actions of leptin Our studies show that AGRP and NPY, previously shown to have nearly identical activities in stimulating food intake and fat deposition (10, 22) , mediate nonoverlapping functions of leptin. In the NPY-null AGRP: Lepr Ϫ/Ϫ mice, AGRP mediates the hyperphagia that is the presumed major effect producing increased fat deposition and obesity. This observation is in line with the report that reconstitution of MC4R within the hypothalamic paraventricular nucleus of Mc4r Ϫ/Ϫ mice ameliorated some of the hyperphagia without affecting energy expenditure (23) . Conversely, for AGRP-null AGRP:Lepr Ϫ/Ϫ mice, NPY is most likely to be the mediator of the lowered energy expenditure and increased adiposity. Qualitatively, either neuropeptide is sufficient to produce obesity in the absence of leptin regulation within the AGRP/NPY neuron albeit via different mechanisms. We do note that we did not observe, for these postpubertal female AGRP: Lepr Ϫ/Ϫ mice, the lowered RER and altered substrate utilization that we reported upon for younger 4-to 6-weekold male AGRP:Lepr Ϫ/Ϫ mice (8), perhaps because of differences in age or sex. We should note that our results apply only to the females as we did not study males because of the large differences in fat-free mass, which is used as a denominator to correct for differences in body mass, that would impose severe complications in the interpretation of the calorimetry data (18, 20) .
Ablation of both AGRP and NPY is necessary to prevent obesity due to loss of leptin signaling in the AGRP/NPY neuron The combined loss of NPY and AGRP in mice without Lepr in AGRP/NPY neurons produced mice with normal body mass and body composition with no observable defects in feeding, energy expenditure, physical activity, and operant responding. These mutant mice were compared with mice that are null for AGRP and NPY, which previously have been shown to be relatively normal in body composition and feeding (17) . We conclude that leptin's regulation of transmission of both AGRP and NPY are important to maintain normal body composition. We were surprised at this conclusion as GABA, the third neurotransmitter released by the AGRP/NPY neuron, is important for maintaining normal adiposity (15) and has been shown to have increased release in leptin signaling deficiency (24) . Thus it would appear that GABA released from AGRP/NPY neurons is not sufficient to produce leptin receptor deficiency mediated obesity in the absence of AGRP and NPY.
It is also clear that any compensatory mechanisms operative in the final production of the phenotypes of mice with lifelong ablation of NPY and/or AGRP could confound the interpretations of our data (25) . Loss of leptin signaling has shown delayed development of projections from arcuate nucleus neurons (26) , although it is unclear whether loss of AGRP or NPY causes any morphological consequences. Thus, we took care to compare only those groups of mice that had similar ablations of neuropeptide gene expression so as to only consider the impact of the loss of Lepr signaling in AGRP/NPY neurons, maintaining an identical state of neuropeptide gene ablation between the comparison groups.
Hyperphagia of leptin signaling deficiency in AGRP/NPY neurons is not attributable to altered reward
Rodents with deficiencies in leptin signaling have increased operant behavior for food rewards. Obese Leprfatty rats have increased acquisition rates for a task and higher response rates for a food reward, compared with lean fats (27) . Obese Lep ob/ob (19) and Mc4r Ϫ/Ϫ (28) mice show higher response rates for a food reward. These rodent models of obesity typically exhibit larger meal sizes than lean control animals. Our failure to observe an increase in operant behavior in the hyperphagic NPY-null AGRP:Lepr Ϫ/Ϫ mice would suggest that the hyperphagia is unlikely to be attributable to a higher perceived reward for food. Surprisingly, we observed an increase in meal frequency which is typically associated with defects in satiation and cholecystokinin signaling (29) rather than meal size as larger meals are typically associated with global leptin signaling defects (30) . There are differences in our measures of food intake: 24-h food intake is done while free feeding whereas the operant feeding was performed for 4 h after a brief deprivation period. Thus, any caloric imbalance incurred during the operant testing could be compensated for during the nonrestricted period. Further studies are likely to be necessary to ascertain the signaling and connectivity differences between our neuron-type specific models of altered LEPR signaling and global ablation of signaling by leptin and melanocortins. In summary, we have found that, in the case of isolated LEPR deficiency of AGRP/NPY neurons, AGRP confers hyperphagia whereas NPY produces reduced energy expenditure. Both neuropeptides produce obesity in a complementary fashion and both neuropeptides must be eliminated to prevent the obesity produced by a leptin signaling defect in the AGRP/NPY neuron. It is possible that the dichotomy of neuropeptide actions could be a result of compensatory mechanisms induced by the loss of a given neuropeptide. Nevertheless, ablation of Lepr signaling within defined neurons reveals critical deficiencies in the neuronal network regulating metabolism and feeding, providing insights into potential modalities for treatments of caloric imbalance.
